Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020

The COVID-19 pandemic and associated non-pharmaceutical interventions (NPIs) affect healthcare seeking behaviour, access to healthcare, test strategies, disease notification and workload at public health authorities, but may also lead to a true change in transmission dynamics. We aimed to assess the...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet regional health. Europe 2021-07, Vol.6, p.100103-100103, Article 100103
Main Authors: Ullrich, Alexander, Schranz, Madlen, Rexroth, Ute, Hamouda, Osamah, Schaade, Lars, Diercke, Michaela, Boender, T. Sonia
Format: Article
Language:English
Subjects:
Cohort studies
COVID-19
Disease transmission, infectious
Epidemiology
General Practitioners
Pandemics
Public health surveillance
Research Paper
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c529t-5e279837df4341f676f6b36c3b5cdfd8cdb88afef5eef2118ad699cc4584e4273
cites cdi_FETCH-LOGICAL-c529t-5e279837df4341f676f6b36c3b5cdfd8cdb88afef5eef2118ad699cc4584e4273
container_end_page 100103
container_issue
container_start_page 100103
container_title The Lancet regional health. Europe
container_volume 6
creator Ullrich, Alexander
Schranz, Madlen
Rexroth, Ute
Hamouda, Osamah
Schaade, Lars
Diercke, Michaela
Boender, T. Sonia
description The COVID-19 pandemic and associated non-pharmaceutical interventions (NPIs) affect healthcare seeking behaviour, access to healthcare, test strategies, disease notification and workload at public health authorities, but may also lead to a true change in transmission dynamics. We aimed to assess the impact of the pandemic and NPIs on other notifiable infectious diseases under surveillance in Germany. We included 32 nationally notifiable disease categories with case numbers >100/year in 2016–2019. We used quasi-Poisson regression analysis on a weekly aggregated time-series incorporating trend and seasonality, to compute the relative change in case numbers during week 2020–10 to 2020–32 (pandemic/NPIs), in comparison to week 2016–01 to 2020–09. During week 2020–10 to 2020–32, 216,825 COVID-19 cases, and 162,942 (-35%) cases of other diseases, were notified. Case numbers decreased across all ages and notification categories (all p
doi_str_mv 10.1016/j.lanepe.2021.100103
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7e37966f5a3040219b07d08297434911</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2666776221000806</els_id><doaj_id>oai_doaj_org_article_7e37966f5a3040219b07d08297434911</doaj_id><sourcerecordid>2576648811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-5e279837df4341f676f6b36c3b5cdfd8cdb88afef5eef2118ad699cc4584e4273</originalsourceid><addsrcrecordid>eNp9ksFu1DAQhiMEolXpGyDkI5ddbCdxEg5IVQtlpUq9AFfLsce7XhI72MmivfEOPBsvwJMwuymlvXAaazz-fvv3n2UvGV0yysSb7bJTHgZYcsoZtiij-ZPslAshFlUl-NMH65PsPKUtpZSXLOeseJ6d5EVZVnXOTrNfq35QeiTBknED5PL2y-pqwRoyKG-gd5pgJSqloJ0awRAf_GLYqNgrDdPotOqI8yPEHfjRBZ9I8CQgKeLk6KxTbQc4YUHj9pSIcQlUgoQ9cg2I8fu35MKjjOr2yaXDRbw6oJCcJuS6Dp-qgRg1KmKm6PyafAf4StjvHz85mkGwzp2cH1ucvsieWdUlOL-rZ9nnD-8_XX5c3Nxery4vbha65M24KIFXTZ1XxhZ5wayohBVtLnTeltpYU2vT1rWyYEsAyxmrlRFNo3VR1gUUvMrPstXMNUFt5RBdr-JeBuXksRHiWqqILnUgK8irRghbqpwW-GlNSytDa95UqN0whqx3M2uY2h6MRkOj6h5BH-94t5HrsJN1URbIQcDrO0AM3yZIo-xd0nCwD9B6yctKiKKuj1rFPKpjSCmCvZdhVB4CJrdyDpg8BEzOAcNjrx5e8f7Q3zj9ewOg6TsHUSbtAH_PuIgJQFfc_xX-AMr35_0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2576648811</pqid></control><display><type>article</type><title>Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020</title><source>Open Access: PubMed Central</source><source>ScienceDirect (Online service)</source><creator>Ullrich, Alexander ; Schranz, Madlen ; Rexroth, Ute ; Hamouda, Osamah ; Schaade, Lars ; Diercke, Michaela ; Boender, T. Sonia</creator><creatorcontrib>Ullrich, Alexander ; Schranz, Madlen ; Rexroth, Ute ; Hamouda, Osamah ; Schaade, Lars ; Diercke, Michaela ; Boender, T. Sonia ; Robert Koch's Infectious Disease Surveillance Group</creatorcontrib><description>The COVID-19 pandemic and associated non-pharmaceutical interventions (NPIs) affect healthcare seeking behaviour, access to healthcare, test strategies, disease notification and workload at public health authorities, but may also lead to a true change in transmission dynamics. We aimed to assess the impact of the pandemic and NPIs on other notifiable infectious diseases under surveillance in Germany. We included 32 nationally notifiable disease categories with case numbers &gt;100/year in 2016–2019. We used quasi-Poisson regression analysis on a weekly aggregated time-series incorporating trend and seasonality, to compute the relative change in case numbers during week 2020–10 to 2020–32 (pandemic/NPIs), in comparison to week 2016–01 to 2020–09. During week 2020–10 to 2020–32, 216,825 COVID-19 cases, and 162,942 (-35%) cases of other diseases, were notified. Case numbers decreased across all ages and notification categories (all p&lt;0•05), except for tick-borne encephalitis, which increased (+58%). The number of cases decreased most for respiratory diseases (from -86% for measles, to -12% for tuberculosis), gastro-intestinal diseases (from -83% for rotavirus gastroenteritis, to -7% for yersiniosis) and imported vector-borne diseases (-75% dengue fever, -73% malaria). The less affected infections were healthcare associated pathogens (from -43% infection/colonisation with carbapenem-non-susceptible Acinetobacter, to -28% for Methicillin-resistant Staphylococcus aureus invasive infection) and sexually transmitted and blood-borne diseases (from -28% for hepatitis B, to -12% for syphilis). During the COVID-19 pandemic a drastic decrease of notifications for most infectious diseases and pathogens was observed. Our findings suggest effects of NPIs on overall disease transmission that require further investigation. The Robert Koch Institute is the National Public Health Institute of Germany, and is an institute within the portfolio of the Federal Ministry of Health.</description><identifier>ISSN: 2666-7762</identifier><identifier>EISSN: 2666-7762</identifier><identifier>DOI: 10.1016/j.lanepe.2021.100103</identifier><identifier>PMID: 34557831</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Cohort studies ; COVID-19 ; Disease transmission, infectious ; Epidemiology ; General Practitioners ; Pandemics ; Public health surveillance ; Research Paper</subject><ispartof>The Lancet regional health. Europe, 2021-07, Vol.6, p.100103-100103, Article 100103</ispartof><rights>2021 The Author(s)</rights><rights>2021 The Author(s).</rights><rights>2021 The Author(s) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-5e279837df4341f676f6b36c3b5cdfd8cdb88afef5eef2118ad699cc4584e4273</citedby><cites>FETCH-LOGICAL-c529t-5e279837df4341f676f6b36c3b5cdfd8cdb88afef5eef2118ad699cc4584e4273</cites><orcidid>0000-0002-4418-3713</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454829/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2666776221000806$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34557831$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ullrich, Alexander</creatorcontrib><creatorcontrib>Schranz, Madlen</creatorcontrib><creatorcontrib>Rexroth, Ute</creatorcontrib><creatorcontrib>Hamouda, Osamah</creatorcontrib><creatorcontrib>Schaade, Lars</creatorcontrib><creatorcontrib>Diercke, Michaela</creatorcontrib><creatorcontrib>Boender, T. Sonia</creatorcontrib><creatorcontrib>Robert Koch's Infectious Disease Surveillance Group</creatorcontrib><title>Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020</title><title>The Lancet regional health. Europe</title><addtitle>Lancet Reg Health Eur</addtitle><description>The COVID-19 pandemic and associated non-pharmaceutical interventions (NPIs) affect healthcare seeking behaviour, access to healthcare, test strategies, disease notification and workload at public health authorities, but may also lead to a true change in transmission dynamics. We aimed to assess the impact of the pandemic and NPIs on other notifiable infectious diseases under surveillance in Germany. We included 32 nationally notifiable disease categories with case numbers &gt;100/year in 2016–2019. We used quasi-Poisson regression analysis on a weekly aggregated time-series incorporating trend and seasonality, to compute the relative change in case numbers during week 2020–10 to 2020–32 (pandemic/NPIs), in comparison to week 2016–01 to 2020–09. During week 2020–10 to 2020–32, 216,825 COVID-19 cases, and 162,942 (-35%) cases of other diseases, were notified. Case numbers decreased across all ages and notification categories (all p&lt;0•05), except for tick-borne encephalitis, which increased (+58%). The number of cases decreased most for respiratory diseases (from -86% for measles, to -12% for tuberculosis), gastro-intestinal diseases (from -83% for rotavirus gastroenteritis, to -7% for yersiniosis) and imported vector-borne diseases (-75% dengue fever, -73% malaria). The less affected infections were healthcare associated pathogens (from -43% infection/colonisation with carbapenem-non-susceptible Acinetobacter, to -28% for Methicillin-resistant Staphylococcus aureus invasive infection) and sexually transmitted and blood-borne diseases (from -28% for hepatitis B, to -12% for syphilis). During the COVID-19 pandemic a drastic decrease of notifications for most infectious diseases and pathogens was observed. Our findings suggest effects of NPIs on overall disease transmission that require further investigation. The Robert Koch Institute is the National Public Health Institute of Germany, and is an institute within the portfolio of the Federal Ministry of Health.</description><subject>Cohort studies</subject><subject>COVID-19</subject><subject>Disease transmission, infectious</subject><subject>Epidemiology</subject><subject>General Practitioners</subject><subject>Pandemics</subject><subject>Public health surveillance</subject><subject>Research Paper</subject><issn>2666-7762</issn><issn>2666-7762</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9ksFu1DAQhiMEolXpGyDkI5ddbCdxEg5IVQtlpUq9AFfLsce7XhI72MmivfEOPBsvwJMwuymlvXAaazz-fvv3n2UvGV0yysSb7bJTHgZYcsoZtiij-ZPslAshFlUl-NMH65PsPKUtpZSXLOeseJ6d5EVZVnXOTrNfq35QeiTBknED5PL2y-pqwRoyKG-gd5pgJSqloJ0awRAf_GLYqNgrDdPotOqI8yPEHfjRBZ9I8CQgKeLk6KxTbQc4YUHj9pSIcQlUgoQ9cg2I8fu35MKjjOr2yaXDRbw6oJCcJuS6Dp-qgRg1KmKm6PyafAf4StjvHz85mkGwzp2cH1ucvsieWdUlOL-rZ9nnD-8_XX5c3Nxery4vbha65M24KIFXTZ1XxhZ5wayohBVtLnTeltpYU2vT1rWyYEsAyxmrlRFNo3VR1gUUvMrPstXMNUFt5RBdr-JeBuXksRHiWqqILnUgK8irRghbqpwW-GlNSytDa95UqN0whqx3M2uY2h6MRkOj6h5BH-94t5HrsJN1URbIQcDrO0AM3yZIo-xd0nCwD9B6yctKiKKuj1rFPKpjSCmCvZdhVB4CJrdyDpg8BEzOAcNjrx5e8f7Q3zj9ewOg6TsHUSbtAH_PuIgJQFfc_xX-AMr35_0</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Ullrich, Alexander</creator><creator>Schranz, Madlen</creator><creator>Rexroth, Ute</creator><creator>Hamouda, Osamah</creator><creator>Schaade, Lars</creator><creator>Diercke, Michaela</creator><creator>Boender, T. Sonia</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4418-3713</orcidid></search><sort><creationdate>20210701</creationdate><title>Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020</title><author>Ullrich, Alexander ; Schranz, Madlen ; Rexroth, Ute ; Hamouda, Osamah ; Schaade, Lars ; Diercke, Michaela ; Boender, T. Sonia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-5e279837df4341f676f6b36c3b5cdfd8cdb88afef5eef2118ad699cc4584e4273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cohort studies</topic><topic>COVID-19</topic><topic>Disease transmission, infectious</topic><topic>Epidemiology</topic><topic>General Practitioners</topic><topic>Pandemics</topic><topic>Public health surveillance</topic><topic>Research Paper</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ullrich, Alexander</creatorcontrib><creatorcontrib>Schranz, Madlen</creatorcontrib><creatorcontrib>Rexroth, Ute</creatorcontrib><creatorcontrib>Hamouda, Osamah</creatorcontrib><creatorcontrib>Schaade, Lars</creatorcontrib><creatorcontrib>Diercke, Michaela</creatorcontrib><creatorcontrib>Boender, T. Sonia</creatorcontrib><creatorcontrib>Robert Koch's Infectious Disease Surveillance Group</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>The Lancet regional health. Europe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ullrich, Alexander</au><au>Schranz, Madlen</au><au>Rexroth, Ute</au><au>Hamouda, Osamah</au><au>Schaade, Lars</au><au>Diercke, Michaela</au><au>Boender, T. Sonia</au><aucorp>Robert Koch's Infectious Disease Surveillance Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020</atitle><jtitle>The Lancet regional health. Europe</jtitle><addtitle>Lancet Reg Health Eur</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>6</volume><spage>100103</spage><epage>100103</epage><pages>100103-100103</pages><artnum>100103</artnum><issn>2666-7762</issn><eissn>2666-7762</eissn><abstract>The COVID-19 pandemic and associated non-pharmaceutical interventions (NPIs) affect healthcare seeking behaviour, access to healthcare, test strategies, disease notification and workload at public health authorities, but may also lead to a true change in transmission dynamics. We aimed to assess the impact of the pandemic and NPIs on other notifiable infectious diseases under surveillance in Germany. We included 32 nationally notifiable disease categories with case numbers &gt;100/year in 2016–2019. We used quasi-Poisson regression analysis on a weekly aggregated time-series incorporating trend and seasonality, to compute the relative change in case numbers during week 2020–10 to 2020–32 (pandemic/NPIs), in comparison to week 2016–01 to 2020–09. During week 2020–10 to 2020–32, 216,825 COVID-19 cases, and 162,942 (-35%) cases of other diseases, were notified. Case numbers decreased across all ages and notification categories (all p&lt;0•05), except for tick-borne encephalitis, which increased (+58%). The number of cases decreased most for respiratory diseases (from -86% for measles, to -12% for tuberculosis), gastro-intestinal diseases (from -83% for rotavirus gastroenteritis, to -7% for yersiniosis) and imported vector-borne diseases (-75% dengue fever, -73% malaria). The less affected infections were healthcare associated pathogens (from -43% infection/colonisation with carbapenem-non-susceptible Acinetobacter, to -28% for Methicillin-resistant Staphylococcus aureus invasive infection) and sexually transmitted and blood-borne diseases (from -28% for hepatitis B, to -12% for syphilis). During the COVID-19 pandemic a drastic decrease of notifications for most infectious diseases and pathogens was observed. Our findings suggest effects of NPIs on overall disease transmission that require further investigation. The Robert Koch Institute is the National Public Health Institute of Germany, and is an institute within the portfolio of the Federal Ministry of Health.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34557831</pmid><doi>10.1016/j.lanepe.2021.100103</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-4418-3713</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2666-7762
ispartof The Lancet regional health. Europe, 2021-07, Vol.6, p.100103-100103, Article 100103
issn 2666-7762
2666-7762
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_7e37966f5a3040219b07d08297434911
source Open Access: PubMed Central; ScienceDirect (Online service)
subjects Cohort studies
COVID-19
Disease transmission, infectious
Epidemiology
General Practitioners
Pandemics
Public health surveillance
Research Paper
title Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T00%3A16%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20the%20COVID-19%20pandemic%20and%20associated%20non-pharmaceutical%20interventions%20on%20other%20notifiable%20infectious%20diseases%20in%20Germany:%20An%20analysis%20of%20national%20surveillance%20data%20during%20week%201%E2%80%932016%20%E2%80%93%20week%2032%E2%80%932020&rft.jtitle=The%20Lancet%20regional%20health.%20Europe&rft.au=Ullrich,%20Alexander&rft.aucorp=Robert%20Koch's%20Infectious%20Disease%20Surveillance%20Group&rft.date=2021-07-01&rft.volume=6&rft.spage=100103&rft.epage=100103&rft.pages=100103-100103&rft.artnum=100103&rft.issn=2666-7762&rft.eissn=2666-7762&rft_id=info:doi/10.1016/j.lanepe.2021.100103&rft_dat=%3Cproquest_doaj_%3E2576648811%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c529t-5e279837df4341f676f6b36c3b5cdfd8cdb88afef5eef2118ad699cc4584e4273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2576648811&rft_id=info:pmid/34557831&rfr_iscdi=true